<DOC>
	<DOCNO>NCT02260063</DOCNO>
	<brief_summary>To assess bioequivalence two galenic formulation epinastine ( FlurinolÂ® ) : syrup 20 mg tablet</brief_summary>
	<brief_title>Relative Bioavailability Epinastine Syrup Compared Tablets Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Epinastine</mesh_term>
	<criteria>male female , nonsmoker nonalcohol user , healthy volunteer , 21 45 year age . To eligible , woman must pregnant lactating must take hormone contraceptives Volunteers must history liver renal disease history psychiatric disorder . Volunteers submit biochemical test list , result must within expect normal value : complete blood count , erythrosedimentation rate , GOT ( glutamate oxalacetate transaminase ) GPT ( glutamate pyruvate transaminase ) , blood creatinine , glycemia , uremia , blood cholesterol , pregnancy test . HIV test ( prior write consent ) , serum test Chagas disease , hepatic b syphilis , complete urinalysis , ECG ( electrocardiogram ) chest xray Volunteers must discontinue pharmacological treatment least two week enter trial inform write consent , sign prior start trial Volunteers require kind pharmacological treatment know addiction Volunteers participate clinical trial four preceding week Volunteers must start treatment incompatible trial course Volunteers comply fasting requirement establish trial comply trial requirement avoid intake coffee , tea , cola soft drink , etc . 24 hour prior start trial History allergy intolerance Epinastine Uncooperative volunteer Previous participation trial</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>